Literature DB >> 28209751

iNKT cell defects in HHV-8-associated MCD.

Thomas S Uldrick1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28209751      PMCID： PMC5314815          DOI： 10.1182/blood-2016-11-751875

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Regulation of CD1d expression and function by a herpesvirus infection.

Authors:  David Jesse Sanchez; Jenny E Gumperz; Don Ganem
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

2.  Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Authors:  Mark N Polizzotto; Thomas S Uldrick; Victoria Wang; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Stefania Pittaluga; Deirdre O'Mahony; Denise Whitby; Giovanna Tosato; Seth M Steinberg; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2013-10-30       Impact factor: 22.113

3.  iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease.

Authors:  Zineb Sbihi; Antoine Dossier; David Boutboul; Lionel Galicier; Christophe Parizot; Amandine Emarre; Bénédicte Hoareau; Nicolas Dupin; Anne-Geneviève Marcelin; Anne Oudin; Claire Fieschi; Félix Agbalika; Brigitte Autran; Eric Oksenhendler; Guislaine Carcelain
Journal:  Blood       Date:  2016-11-09       Impact factor: 22.113

4.  Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis.

Authors:  L Coscoy; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.

Authors:  Amelie Guihot; Nicolas Dupin; Anne-Genevieve Marcelin; Isabelle Gorin; Anne-Sophie Bedin; Philippe Bossi; Lionel Galicier; Eric Oksenhendler; Brigitte Autran; Guislaine Carcelain
Journal:  J Infect Dis       Date:  2006-09-15       Impact factor: 5.226

6.  Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.

Authors:  Thomas S Uldrick; Mark N Polizzotto; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Denise Whitby; Victoria Wang; Stefania Pittaluga; Deirdre O'Mahony; Seth M Steinberg; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

7.  The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.

Authors:  T Powles; J Stebbing; A Bazeos; E Hatzimichael; S Mandalia; M Nelson; B Gazzard; M Bower
Journal:  Ann Oncol       Date:  2009-01-29       Impact factor: 32.976

8.  Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells.

Authors:  Amélie Guihot; Eric Oksenhendler; Lionel Galicier; Anne-Geneviève Marcelin; Laura Papagno; Anne-Sophie Bedin; Félix Agbalika; Nicolas Dupin; Jacques Cadranel; Brigitte Autran; Guislaine Carcelain
Journal:  Blood       Date:  2007-11-13       Impact factor: 22.113

9.  Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.

Authors:  Johan K Sandberg; Noam M Fast; Emil H Palacios; Glenn Fennelly; Joanna Dobroszycki; Paul Palumbo; Andrew Wiznia; Robert M Grant; Nina Bhardwaj; Michael G Rosenberg; Douglas F Nixon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Authors:  Robert J Biggar; Anil K Chaturvedi; James J Goedert; Eric A Engels
Journal:  J Natl Cancer Inst       Date:  2007-06-12       Impact factor: 13.506
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.